| Inflammatory Bowel Disease |
1 |
1 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.99 |
| Biologic Therapy |
0 |
0.71 |
| Antibiotics |
0 |
0.98 |
| Microbiome |
0 |
0.97 |
| Metabolism |
0 |
0.28 |
| Biomarker |
0 |
0.09 |
| Board Certification |
0 |
0.09 |
| Colitis |
0 |
0.09 |
| Epidemiology |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Immunization |
0 |
0.09 |
| Immunocompromise |
0 |
0.09 |
| Manipulation |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.09 |
| Remission |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Ulcerative Colitis |
0 |
0.05 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.04 |
| Crohn Disease |
0 |
0.04 |
| HIV Infection |
0 |
0.04 |